fbpx

Convalescent Plasma Therapy 

  • IASbaba
  • April 1, 2020
  • 0
UPSC Articles
Print Friendly, PDF & Email

Convalescent Plasma Therapy 

Part of: GS Prelims and GS-II – Health 

In News:

  • The US Food and Drug Administration (FDA) approved use of blood plasma from recovered patients to treat severely critical COVID-19 patients.
  • This process is called convalescent plasma therapy. 

Key takeaways:

  • Convalescent plasma therapy seeks to make use of the antibodies developed in the recovered patient against the coronavirus.
  • The whole blood or plasma (the colourless fluid part of blood) is taken from recovered patient. 
  • The plasma is then injected in critically ill patients to transfer the antibodies and boost their fight against the virus.

Important value additions:

  • A COVID-19 patient usually develops primary immunity against the virus in 10-14 days. 
  • If the plasma is injected at an early stage, it can possibly help fight the virus and prevent severe illness. 

For a dedicated peer group, Motivation & Quick updates, Join our official telegram channel – https://t.me/IASbabaOfficialAccount

Search now.....